{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:34Z","timestamp":1792784494130,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["CA149363"],"award-info":[{"award-number":["CA149363"]}]},{"name":"NIH","award":["CA151652"],"award-info":[{"award-number":["CA151652"]}]},{"name":"NIH","award":["CA149387"],"award-info":[{"award-number":["CA149387"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ymthe.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T14:30:32Z","timestamp":1511361032000},"page":"420-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma"],"prefix":"10.1016","volume":"26","author":[{"given":"Yuhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leaf","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.11.009_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1586\/14760584.2015.957685","article-title":"The ReNAissanCe of mRNA-based cancer therapy","volume":"14","author":"Van Lint","year":"2015","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ymthe.2017.11.009_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jgm.615","article-title":"Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells","volume":"6","author":"Breckpot","year":"2004","journal-title":"J.\u00a0Gene Med."},{"key":"10.1016\/j.ymthe.2017.11.009_bib3","first-page":"347","article-title":"Development of a dendritic cell (DC)-based vaccine for patients with advanced colorectal cancer","volume":"48","author":"Rains","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ymthe.2017.11.009_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/CJI.0b013e31815ce501","article-title":"Results of the first phase I\/II clinical vaccination trial with direct injection of mRNA","volume":"31","author":"Weide","year":"2008","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2017.11.009_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40425-015-0068-y","article-title":"Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I\/IIa study","volume":"3","author":"K\u00fcbler","year":"2015","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2017.11.009_bib6","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/mt.2010.289","article-title":"Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients","volume":"19","author":"Rittig","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.11.009_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/CJI.0b013e3181a00068","article-title":"Direct injection of protamine-protected mRNA: results of a phase 1\/2 vaccination trial in metastatic melanoma patients","volume":"32","author":"Weide","year":"2009","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2017.11.009_bib8","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0830997100","article-title":"Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients","volume":"100","author":"Hodi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.11.009_bib9","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2017.11.009_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2011.10.020","article-title":"Calcium phosphate nanoparticles with an asymmetric lipid bilayer coating for siRNA delivery to the tumor","volume":"158","author":"Li","year":"2012","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.11.009_bib12","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/mp300152v","article-title":"Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer","volume":"9","author":"Yang","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2017.11.009_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2013.08.021","article-title":"Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis","volume":"172","author":"Xu","year":"2013","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.11.009_bib14","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1016\/j.biomaterials.2013.07.050","article-title":"Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2017.11.009_bib15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.11.009_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5\u2032-triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.11.009_bib17","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1126\/science.1147347","article-title":"5\u2032-triphosphate-dependent activation of PKR by RNAs with short stem-loops","volume":"318","author":"Nallagatla","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.11.009_bib18","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2017.11.009_bib19","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2015.103","article-title":"Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals","volume":"23","author":"Thess","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.11.009_bib20","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","article-title":"Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA","volume":"7","author":"Warren","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2017.11.009_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/mt.2012.250","article-title":"Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy","volume":"21","author":"Wang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.11.009_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nbt.1733","article-title":"Expression of therapeutic proteins after delivery of chemically modified mRNA in mice","volume":"29","author":"Kormann","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/cbr.2009.0714","article-title":"Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity","volume":"25","author":"Xie","year":"2010","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.ymthe.2017.11.009_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4161\/rna.5.3.6839","article-title":"A brilliant disguise for self RNA: 5\u2032-end and internal modifications of primary transcripts suppress elements of innate immunity","volume":"5","author":"Nallagatla","year":"2008","journal-title":"RNA Biol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/bit.20059","article-title":"Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells","volume":"86","author":"Ignowski","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ymthe.2017.11.009_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1128\/CDLI.11.1.77-82.2004","article-title":"Calcium signaling through phospholipase C activates dendritic cells to mature and is necessary for the activation and maturation of dendritic cells induced by diverse agonists","volume":"11","author":"Bagley","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib27","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.4049\/jimmunol.159.8.3823","article-title":"Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells","volume":"159","author":"Czerniecki","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4049\/jimmunol.163.1.82","article-title":"Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways","volume":"163","author":"Koski","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2008.05.005","article-title":"Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine","volume":"130","author":"Yan","year":"2008","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2017.11.009_bib30","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s00018-004-4255-0","article-title":"Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines","volume":"61","author":"Carralot","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2017.11.009_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#","article-title":"In\u00a0vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies","volume":"30","author":"Hoerr","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.ymthe.2017.11.009_bib33","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1016\/j.biomaterials.2014.02.030","article-title":"Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT\/CT imaging of lymph node metastases","volume":"35","author":"Tseng","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2017.11.009_bib34","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s11095-011-0464-z","article-title":"PEGylation improves nanoparticle formation and transfection efficiency of messenger RNA","volume":"28","author":"Uzg\u00fcn","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymthe.2017.11.009_bib35","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1016\/j.biomaterials.2012.06.020","article-title":"Multifunctional triblock copolymers for intracellular messenger RNA delivery","volume":"33","author":"Cheng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2017.11.009_bib36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.11.009_bib37","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.ymthe.2017.11.009_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201601412","article-title":"Arginine-rich peptide-based mRNA nanocomplexes efficiently instigate cytotoxic T\u00a0cell immunity dependent on the amphipathic organization of the peptide","volume":"6","author":"Udhayakumar","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2017.11.009_bib39","doi-asserted-by":"crossref","first-page":"C1205","DOI":"10.1152\/ajpcell.00039.2011","article-title":"Ca2+ signaling in the regulation of dendritic cell functions","volume":"300","author":"Shumilina","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib41","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00262-006-0266-z","article-title":"Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and\u00a0postoperative prognosis in human urothelial cancers","volume":"56","author":"Nakanishi","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2017.11.009_bib42","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2017.11.009_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00109-003-0430-2","article-title":"B7-H1 pathway and its role in the evasion of tumor immunity","volume":"81","author":"Dong","year":"2003","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.ymthe.2017.11.009_bib44","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","article-title":"Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T\u00a0cells as a mechanism of immune evasion: implications for tumor immunotherapy","volume":"54","author":"Blank","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2017.11.009_bib45","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","article-title":"Breakthrough of the year 2013. Cancer immunotherapy","volume":"342","author":"Couzin-Frankel","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2017.11.009_bib46","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1-deficient mice show that PD-L1 on T\u00a0cells, antigen-presenting cells, and host tissues negatively regulates T\u00a0cells","volume":"101","author":"Latchman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.11.009_bib47","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.1790","article-title":"Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal","volume":"10","author":"Fife","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2017.11.009_bib48","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1021\/nn500216y","article-title":"Nanoparticle-delivered transforming growth factor-\u03b2 siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment","volume":"8","author":"Xu","year":"2014","journal-title":"ACS Nano"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617305683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617305683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T19:33:55Z","timestamp":1693251235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617305683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1525001617305683"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.11.009","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}